Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Exagen Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 47 | 38 | −9 |
| Shares | 10.7M | 7.93M | −2.79M (−26.0%) |
| Value | $46.1M | $21.4M | −$24.7M (−53.5%) |
New holders (3)
Institutions that held Exagen Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allworth Financial LP | 7,015 | $19.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 169 | $458 | 0.00% |
| Tower Research Capital LLC (TRC) | 35 | $0 | 0.00% |
Sold out (12)
Institutions that held Exagen Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 27,996 | $160.0K |
| Susquehanna International Group, LLP | 16,914 | $97.0K |
| Truist Financial Corp | 11,740 | $67.0K |
| Intrust Bank NA | 10,031 | $57.0K |
| Russell Investments Group, Ltd. | 3,439 | $19.0K |
| Captrust Financial Advisors | 340 | $2.00K |
| FMR LLC | 165 | $1.00K |
| New York State Common Retirement Fund | 97 | $1.00K |
| Citigroup Inc | 92 | $1.00K |
| Capital Advisors, Ltd. LLC | 161 | $1.00K |
| Credit Suisse AG | 5 | $0 |
| HighTower Trust Services, LTA | 2,683,578 | – |